← Leaderboards
Christine M Posavad
University Of Washington
$3,753,026
Attributed
$3,753,026
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $421.4K · FY2005–15$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$3,753,026 · 4
By mechanism
R01$3,069,353 · 2
R21$414,605 · 1
K22$269,068 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Washington
Same institution · by research overlap
- Jeanne M Marrazzo$22,158,899
- Laura A Koutsky$14,115,377
- Anna Wald$34,443,936
- Matthew R Golden$9,979,404
- Rachel L. Winer$10,191,453
Others in their field
Top investigators on “Genital Herpes”
- Connie L Celum · University Of Washington$20,273,946
- Jay B Jackson · Johns Hopkins University$17,529,470
- Betsy C. Herold · Children'S Hospital Med Ctr (Cincinnati)$17,437,390
- David A. Leib · Dartmouth College$14,103,659
- Ekaterina Heldwein · Children'S Hospital Boston$12,561,536
- Akiko Iwasaki · Yale University$12,197,405
Research focus
Genital HerpesSexually Transmitted DiseasesCellular ImmunityClinical ResearchImmunityPreventPreventionSeroprevalencesInfectionInfection PreventionMucous MembranePandemic DiseaseGenital SystemRecording Of Previous EventsLink1 Year OldImmuneHuman Herpesvirus 2Immune ResponseFutureExposure ToProteinsDesignResistance
Grant awards (13)
T Cell Immunity to HSV-2 in Immune Seronegative Subjects$421,409
R01 · FY2015 · AI · contact PI
T Cell Immunity to HSV-2 in Immune Seronegative Subjects$420,699
R01 · FY2014 · AI · contact PI
T Cell Immunity to HSV-2 in Immune Seronegative Subjects$393,833
R01 · FY2013 · AI · contact PI
T Cell Immunity to HSV-2 in Immune Seronegative Subjects$328,511
R01 · FY2012 · AI · contact PI
T Cell Immunity to HSV-2 in Immune Seronegative Subjects$349,985
R01 · FY2011 · AI · contact PI
Innate Resistance to Mucosal HSV Infection in Humans$178,419
R21 · FY2010 · AI · contact PI
Innate Resistance to Mucosal HSV Infection in Humans$236,186
R21 · FY2009 · AI · contact PI
Human Resistance to Herpes Simplex Virus Infections$280,845
R01 · FY2005 · AI
Human Resistance to Herpes Simplex Virus Infections$280,845
R01 · FY2004 · AI
Human Resistance to Herpes Simplex Virus Infections$280,845
R01 · FY2003 · AI
Human Resistance to Herpes Simplex Virus Infections$312,381
R01 · FY2002 · AI
HSV-SERONEGATIVE PERSONS WITH AQUIRED IMMUNITY TO HSV$108,000
K22 · FY2002 · AI
HSV-SERONEGATIVE PERSONS WITH AQUIRED IMMUNITY TO HSV$161,068
K22 · FY2001 · AI